April 2018 Issue of The Translational Scientist

View Issue
Register here to download any issue of The Translational Scientist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Translational Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Disease Area Diagnostics & prognostics

Variant Database Collaborations – for Cancer and Beyond

| Obi Griffith and Heidi Rehm

It's important to research relevant academic papers, but it's equally important to make sure it's still relevant
Tools & Techniques Omics

Translational Proteomics: Solving the Reproducibility Riddle

| David Chiang

Data analysis in proteomics is not fit for purpose – but here’s how we can get on track
Research Field Neuroscience

VEGF Veteran

| Napoleone Ferrara

Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.
Research Field Cell & gene therapy

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?
Outside the Lab Analytical science

Faster for Pharma

| Melissa Hanna-Brown

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.
Outside the Lab Drug discovery

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.
Disease Area Cancer

Anticipating NRAS Resistance

| William Aryitey

How researchers are unraveling the mystery of melanoma drug resistance
Tools & Techniques Cancer

The Esophageal Balloon

| Sanford Markowitz

The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer
Research Field Drug discovery

Through the Looking Glass

| Niek Buurma

There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.

Other issues of 2018